Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors
Language English Country Great Britain, England Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
23462716
DOI
10.1016/j.bmc.2013.01.052
PII: S0968-0896(13)00091-6
Knihovny.cz E-resources
- MeSH
- Acetylcholinesterase metabolism MeSH
- Hep G2 Cells MeSH
- Butyrylcholinesterase metabolism MeSH
- Cholinesterase Inhibitors chemical synthesis chemistry pharmacology toxicity MeSH
- Halogenation MeSH
- Carbamates chemical synthesis chemistry pharmacology toxicity MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Molecular Docking Simulation MeSH
- Thiazoles chemical synthesis chemistry pharmacology toxicity MeSH
- Cell Survival drug effects MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Acetylcholinesterase MeSH
- Butyrylcholinesterase MeSH
- Cholinesterase Inhibitors MeSH
- Carbamates MeSH
- Thiazoles MeSH
A series of novel cholinesterase inhibitors based on 2-substituted 6-fluorobenzo[d]thiazole were synthesised and characterised by IR, (1)H, (13)C and (19)F NMR spectroscopy and HRMS. Purity was checked by elemental analyses. The novel carbamates were tested for their ability to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The toxicity of the most active compounds was investigated using a standard in vitro test with HepG2 cells, and the ratio between biological activity and toxicity was determined. In addition, the toxicity of the most active compounds was evaluated against MCF7 cells using the xCELLigence system. Structure-activity relationships reflecting the dependence of cholinesterase inhibitors on the lipophilicity of the compounds as well as on the Taft polar and steric substituent constants are discussed. The specific orientation of the inhibitors in the binding site of acetylcholinesterase was determined using molecular docking of the most active compound.
References provided by Crossref.org
Heterocycles in Medicinal Chemistry II
Editorial of Special Issue "Current Trends in Chemistry Towards Biology"
Study of Biological Activities and ADMET-Related Properties of Novel Chlorinated N-arylcinnamamides
Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE
Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors
Proline-Based Carbamates as Cholinesterase Inhibitors
Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates